Lumoe Well Respiratory Relief Tablet, Chewable
NDC Package 81425-005-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Lumoe Well Respiratory Relief (crotalus horridus, sticta pulmonaria, viola odorata) tablets is uses* Temporarily Relieves Minor and Occasional Respiratory Symptoms:• fever • cough • headache. This formulation utilizes a tablet, chewable delivery system. Marketed by Applied Bioenergetics, Llc, this product is identified by NDC 81425-005.

Identification & Billing

NDC Package Code
81425-005-10
Package Description
180 TABLET, CHEWABLE in 1 BOTTLE
Product Code
81425-005
11-Digit Billing Format
81425000510

Clinical Specifications

Proprietary Name
Lumoe Well Respiratory Relief
Non-Proprietary Name
Crotalus Horridus, Sticta Pulmonaria, Viola Odorata
Substance Name
Crotalus Horridus Horridus Venom; Lobaria Pulmonaria; Viola Odorata
Dosage Form
Tablet, Chewable - A solid dosage form containing medicinal substances with or without suitable diluents that is intended to be chewed, producing a pleasant tasting residue in the oral cavity that is easily swallowed and does not leave a bitter or unpleasant after-taste.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
Uses* Temporarily Relieves Minor and Occasional Respiratory Symptoms:• fever • cough • headache

Regulatory & Marketing

Labeler Name
Applied Bioenergetics, Llc
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
09-27-2024
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 81425-005-10 identifies a specific commercial package of 180 tablet, chewable in 1 bottle of Lumoe Well Respiratory Relief, a human over the counter drug labeled by Applied Bioenergetics, Llc. This tablet, chewable is formulated for oral use and contains crotalus horridus horridus venom; lobaria pulmonaria; viola odorata as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Applied Bioenergetics, Llc on September 27, 2024. The current certification is valid through December 31, 2026.

How is this Applied Bioenergetics, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 81425000510. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
81425-005-10
11-Digit CMS (5-4-2)
81425-0005-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.